Urotensin II in Chronic Kidney Diseases and Kidney Transplants
The investigators are planning to study the serum level of Urotensin II in chronic kidney disease patients, kidney transplants, and healthy controls.
Chronic Renal Disease
|Study Design:||Time Perspective: Prospective|
|Official Title:||Urotensin II in Chronic Kidney Diseases|
- serum Urotensin II(UII)level [ Time Frame: at enrollment ] [ Designated as safety issue: No ]We tried to compare UII level in normal, chronic kidney disease and kidney transplant patients group
|Study Start Date:||April 2010|
|Study Completion Date:||July 2010|
|Primary Completion Date:||July 2010 (Final data collection date for primary outcome measure)|
Chronic kidney disease-1
Chronic kidney disease not taking dialysis treatment
The investigators will determine the urotensin II levels in Chronic kidney disease patients, kidney transplants, and healthy controls.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01098799
|Vakif Gureba Training & Research Hospital|
|Istanbul, Turkey, 34100|
|Study Director:||Tufan Tukek, MD||Vakif Gureba Training & Research Hospital|